check_circleStudy Completed
Magnetic Resonance Imaging
Bayer Identifier:
Trial_202-14_88488
ClinicalTrials.gov Identifier:
Not Available
EudraCT Number:
Not Available
EU CT Number:
Not Available
Gadopentetate Dimeglumine as an MRI Contrast Agent in Pediatric Patients Presenting with Symptoms of Central Nervous System Lesions
Trial purpose
Please see attached Study Results Summary below
Key Participants Requirements
Sex
N/AAge
3 - 17 YearsTrial summary
Enrollment Goal
14Trial Dates
August 1987 - December 1987Phase
Phase 3Could I Receive a placebo
N/AProducts
Magnevist (Gadopentetate Dimeglumine, BAY86-4882)Accepts Healthy Volunteer
N/ATrial design
Trial Type
InterventionalIntervention Type
N/ATrial Purpose
N/AAllocation
N/ABlinding
N/AAssignment
N/ATrial Arms
N/A